Molecule intelOpportunity: Moderate0

Lacosamide

40 brands · 28 companies · product forms

1 DRAP alert

Opportunity snapshot

Launch attractiveness
43
Market saturation
73
Price room
100
Regulatory risk
50
40
brands
28
companies
Rs 507.15
median price
34
price points
10.33x
price spread
90
confidence %

Who competes here

Top companies by brand count — fragmented market (no dominant player) · leader share 5%

Price room

Across observed sources and strengths
CheapestRs 145.27
MedianRs 507.15
Most expensiveRs 1,499.96
Spread10.33×
Sources: DRAP-official, DVAGO, Servaid

max/min price ratio 10.33x across 34 trusted points (Rs 145.27-1499.96). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Brands & products on the market

Sample of 12 live products for Lacosamide — each links to its own medicine page.

Regulatory alerts

Recall exposurelatest 2025-02-25
Recall Alert: Voluntary Recall of all Batches of Lacolep Injection 10mg/ml Manufactured by

Why this score

Launch attractiveness

40% supply-gap(20) + 25% price-variation(100) + 20% low-competition(27) + 15% supply-disruption(40), damped by confidence(90). Higher = more attractive, less crowded opportunity.

Market saturation

28 canonical companies and 40 brands compete (saturation pegged at 30 companies / 150 brands).

Price room

max/min price ratio 10.33x across 34 trusted points (Rs 145.27-1499.96). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Regulatory risk

1 DRAP alert(s), latest 2025-02-25 incl. recall/safety.

Confidence

Reduced by: no ATC code.

Packaged brief for this moderate opportunity?

Molecule page + company profiles + price-room analysis are the pilot package for pharma teams.

See packaged reports All 3868 molecules

Molecule intelligence as of 2026-07-30. Brand/company counts from DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.